SI-BONE, Inc. (NASDAQ:SIBN) Q3 2023 Earnings Call Transcript

Page 5 of 5

So very excited about the impending launch. And as I think your question highlights a very capital-efficient model that we have here too, because we do not need new instrument trades in order for surgeons to use the new Granite line extension.

Operator: Thank you. I would now like to turn the conference back to Laura Francis for closing remarks. Laura?

Laura Francis: Thanks so much. Before I end the call, I just wanted to thank you all for your participation. The strength of the business is reflected in our impressive year-to-date performance and the increase in guidance for the third time this year. And I’ve said it many times, but with nearly $0.5 million targeted annual procedures in the ultra-state, I firmly believe we’re positioned to drive sustainable long-term and profitable revenue growth. Anshul and I look forward to seeing you. We’re going to be at the Jefferies London Conference as well as the Piper New York Conference, and we also have an NDR planned for Boston in New York later this month. Thank you and goodbye.

Operator: This concludes today’s conference call. Thank you for participating. You may now disconnect.

Follow Si-Bone Inc. (NASDAQ:SIBN)

Page 5 of 5